Cycurion Announces Five New Contracts Totaling $1 Million, Expanding into Commercial Sectors
Cycurion (NASDAQ: CYCU) announced five new contracts closed in September 2025 totaling approximately $1 million, expected to add about $75,000 in monthly recurring revenue. Four of the contracts are in the healthcare and pharmaceutical sectors, and the company cites its relationship with NACCHO as a contributor to those wins.
The deals deploy Cycurion’s Cyber Shield suite and signal an explicit push into commercial and non‑government markets, supporting the company’s stated strategy to broaden customers and sustain revenue growth. Management says further expansions will be announced in coming quarters.
Cycurion (NASDAQ: CYCU) ha annunciato cinque nuovi contratti chiusi a settembre 2025 per un importo totale di circa $1 milione, previsti per generare circa $75.000 di ricavi ricorrenti mensili. Quattro contratti riguardano i settori sanitario e farmaceutico, e l'azienda cita la sua relazione con NACCHO come contributo a tali successi.
Gli accordi prevedono l'uso della suite Cyber Shield di Cycurion e segnano una spinta esplicita verso mercati commerciali e non governativi, supportando la strategia dichiarata dall'azienda di ampliare la base clienti e sostenere la crescita dei ricavi. Il management afferma che ulteriori espansioni saranno annunciate nei prossimi trimestri.
Cycurion (NASDAQ: CYCU) anunció cinco nuevos contratos cerrados en septiembre de 2025 por un importe total de aproximadamente $1 millón, se espera que aporten alrededor de $75.000 en ingresos recurrentes mensuales. Cuatro de los contratos se encuentran en los sectores de atención sanitaria y farmacéutico, y la empresa cita su relación con NACCHO como un factor en estos acuerdos.
Los acuerdos despliegan la suite Cyber Shield de Cycurion y señalan un empuje explícito hacia mercados comerciales y no gubernamentales, apoyando la estrategia de la empresa de ampliar su base de clientes y sostener el crecimiento de ingresos. La dirección afirma que se anunciarán más expansiones en los próximos trimestres.
사이큐리온(CYCU)은 2025년 9월에 체결된 다섯 건의 신규 계약을 발표했으며 총액은 약 $1백만이고, 월평균 재발 수익으로 약 $75,000를 창출할 것으로 예상됩니다. 이 계약 중 네 건은 보건의료 및 제약 부문에 속하며, 기업은 NACCHO와의 관계를 이러한 성과의 기여 요인으로 꼽습니다.
거래는 Cycurion의 Cyber Shield suite를 도입하고 상업적 및 비정부 시장으로의 명시적 확장을 시사하며, 고객 다변화와 수익 성장 유지라는 회사의 전략을 뒷받침합니다. 경영진은 향후 분기에 더 많은 확장 소식을 발표할 것이라고 말합니다.
Cycurion (NASDAQ: CYCU) a annoncé cinq nouveaux contrats clôturés en septembre 2025 pour un montant total d’environ 1 million de dollars, devant générer environ 75 000 dollars de revenus récurrents mensuels. Quatre des contrats relèvent des secteurs de la santé et pharmaceutique, et l’entreprise cite sa relation avec NACCHO comme un facteur de réussite.
Les accords déploient la suite Cyber Shield de Cycurion et marquent une poussée explicite vers les marchés commerciaux et non gouvernementaux, soutenant la stratégie de l’entreprise d’élargir sa base de clients et de maintenir la croissance des revenus. La direction indique que d’autres expansions seront annoncées dans les prochains trimestres.
Cycurion (NASDAQ: CYCU) gab fünf neue Verträge bekannt, die im September 2025 abgeschlossen wurden und insgesamt ca. 1 Million USD umfassen, und voraussichtlich etwa 75.000 USD monatlich an wiederkehrenden Einnahmen bringen. Vier der Verträge entfallen auf den Gesundheits- und Pharma-Sektor, und das Unternehmen führt seine Beziehung zu NACCHO als Mitverantwortlichen für diese Erfolge an.
Die Deals setzen Cycurions Cyber Shield-Suite ein und signalisieren eine klare Ausrichtung auf kommerzielle und nicht-staatliche Märkte, was die vom Unternehmen erklärte Strategie unterstützt, Kunden zu diversifizieren und das Umsatzwachstum zu sichern. Das Management sagt, dass weitere Expansionen in den kommenden Quartalen angekündigt werden.
Cycurion (NASDAQ: CYCU) أعلنت عن خمسة عقود جديدة أُغلِقت في سبتمبر 2025 بإجمالي يقرب من $1 مليون، ومن المتوقع أن تضيف نحو $75,000 من الإيرادات المتكررة الشهرية. أربعة من العقود في قطاعات الرعاية الصحية والصناعات الدوائية، وتذكر الشركة أن علاقتها مع NACCHO ساهمت في هذه الإنجازات.
تستخدم الصفقات حزمة Cycurion Cyber Shield وتُشير إلى دفقة صريحة نحو الأسواق التجارية وغير الحكومية، داعمة الإستراتيجية التي أعلنتها الشركة لتوسيع قاعدة العملاء والحفاظ على نمو الإيرادات. قالت الإدارة إنه سيتم إعلان المزيد من التوسعات في الأرباع القادمة.
Cycurion (NASDAQ: CYCU) 宣布在2025年9月完成的五份新合约，总额约为$1,000,000，预计将带来每月约$75,000的经常性收入。四份合约属于医疗保健和制药行业，公司将NACCHO的关系作为这些胜利的贡献因素之一。
交易部署了Cycurion的Cyber Shield套件，并明确向商业和非政府市场的推进，支持公司扩大客户群、维持收入增长的既定策略。管理层表示，未来几个季度将宣布更多扩张。
- $1.0M in contracts closed in September 2025
- Adds $75,000 in expected monthly recurring revenue
- Four of five contracts target healthcare and pharmaceutical sectors
- Cyber Shield deployed across new commercial customers
- Concentration risk: 4 of 5 contracts are healthcare-related
Insights
Five contracts add
Cycurion converts government-grade technology to commercial revenue by selling its Cyber Shield suite to four healthcare/pharma customers and one other commercial client. The contracts total
Execution depends on customer onboarding, retention, and contract duration, which the release does not specify; these factors determine near-term cash flow and margin contribution. Healthcare deals can require extended integration and compliance work, which may delay revenue recognition or raise costs.
Watch for disclosed contract durations, implementation milestones, and retention metrics over the next
Strategic Wins in Pharmaceutical and Healthcare Underscore Push into Non-Government Markets with Cyber Shield Solutions
MCLEAN, Va., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cycurion (NASDAQ: CYCU), a leading provider of cybersecurity solutions, today announced the successful closure of five new contracts in September, totaling approximately
The contracts include four in the healthcare and pharmaceutical industries. Cycurion’s established relationship and experience with NACCHO (National Association of County and City Health Officials) played a key role in securing these healthcare-related deals, enabling the company to leverage its expertise in protecting sensitive data and infrastructure in these critical areas.
“This milestone reflects our deliberate strategy, as communicated to the market, to accelerate expansion into commercial and non-government sectors,” said Kevin Kelly, CEO of Cycurion. “By deploying our flagship Cyber Shield products, we’re empowering clients with robust, scalable cybersecurity solutions that address evolving threats. These wins not only validate our approach but also position Cycurion for sustained revenue growth.”
Cyber Shield, Cycurion’s comprehensive suite of cybersecurity tools, offers advanced threat detection, encryption, and compliance features tailored for diverse industries. The new contracts highlight the product’s versatility and market demand beyond traditional government clients.
Cycurion remains committed to innovation and client success, with plans to announce further expansions in the coming quarters.
About Cycurion
Cycurion (NASDAQ: CYCU) is a cybersecurity firm dedicated to safeguarding digital assets through cutting-edge technology and strategic partnerships. With a focus on commercial, healthcare, and government sectors, Cycurion delivers solutions that protect against cyber threats while ensuring regulatory compliance.
More info: www.cycurion.com
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.
Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company’s investigations, any potential legal proceedings, including the John Doe lawsuit, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.
Cycurion Investor Relations:
(888) 341-6680
investors@cycurion.com
Cycurion Media Relations:
(888) 341-6680
media@cycurion.com
FAQ
What did Cycurion (CYCU) announce on October 16, 2025 about new contracts?
How much monthly recurring revenue will the CYCU contracts add?
How many of the new CYCU contracts are in healthcare or pharmaceutical industries?
What product will Cycurion deploy under the new CYCU contracts?
Does Cycurion cite any partnerships that helped win the new CYCU contracts?
What does the CYCU contract news mean for the company’s market focus?
